Figures iepresent actual number ofpatients experiencing each type of intolerance. Some experienced more than one kind, either concurrently or as a result of a 'shift'. Loss of desire or distaste attributable to anorexia, or to previous alcohol symptoms, is excluded Assessment may be difficult, especially when a patient is not prepared to risk further alcohol after a single incident. Cases where there was any doubt were fully documented, then classified on the spot as 'probable' or 'possible' without regard to time of onset or probability of being related to the disease. 'Probable' cases were later found to be more than 3 times as common in the cervix group (cervix 27, breast 8) and were accepted. 'Possible' cases were all rejected.
The incidence is as high as that previously found to apply only to 'regular drinkers' (Brewin 1966a ). This appears to be due mainly to the use of even greater care and tact when taking the history, with absolute privacy in every case and a consistent policy of continuing to talk for several minutes to any patient who initially denied intolerance or said that she did not take alcohol; paying particular attention to family celebrations, toasts at weddings or christenings, and to medicinal use, yet avoiding leading questions about specific types of intolerance. As a result, the incidence in regular drinkers shows no significant difference (cervix 12 out of 17 in the new series, 10 out of 19 in the old; breast 3 out of 20, previously 2 out of 20), whereas the incidence in those not in the 'drinkers' category shows a remarkable change (cervix now 25 out of 49, previously 1 out of 34).
The proportion of cervix and breast cases showing either a local effect at the tumour site, abolition of intolerance by radiotherapy or surgery, or onset within a 3-year period before or after diagnosis, is not significantly different (cervix 50 out of 64, breast 10 out of 16: P >0-05). Very few of the other cases show any positive suggestion of not being similarly related to the tumour, evidence being frequently lacking due to a natural reluctance to resume alcohol.
Of the 54 cervix patients whose intolerance was present before diagnosis, 36 (67%) had experienced it for more than a year, including 20 (37 %) for more than 3 years. Of 34 Stage 1 cases, 14 showed intolerance. Of 8 carcinoma-in-situ, 4 showed it. In theory, therefore, these reactions to alcohol could make a significant contribution to earlier diagnosis. Although there are many other causes, some benign, it would seem sensible for any woman who develops alcohol intolerance to have at least a clinical and cytological check on her cervix. Osteosarcoma is the most common primary tumour of bone in both man and dog. The condition is common in middle age in the dog whereas in man two-thirds of the cases occur in the first three decades of life. Malignant change occurs in some cases of Paget's disease in man but Paget's disease does not appear to occur in the dog. The great majority of osteosarcomas arise in the metaphysis of a long bone in both species. Common sites in man are distal femur and proximal tibia. Tumours occur in these sites in the dog but more commonly the proximal humerus and distal radius are involved. These are non-weight-bearing areas in man and the incidence of osteosarcoma is low. Osteosarcoma is much more common in large dogs than small dogs and there appears to be a very high incidence in the Great Dane. The possibility that in some strains of this breed the tumour may be hereditary is worth further investigation. Familial cases occur in man but are rare. The radiographical and histological features are similar in both species butjuxtacortical (parosteal) osteosarcoma has not been described in the dog. The growth rate is faster and onset of lung metastases usually much earlier in the dog than in man as would be expected in an animal of shorter life span.
Comparative Aspects of Bone
The five-year survival rate in man varies from 5 % to 22% according to various series of cases recorded in the literature. Treatment is usually by amputation or X-irradiation followed by amputation. The results following amputation in the dog indicate that the tumour is at least as malignant as in man. Radiotherapy has generally been found unsatisfactory; alkylating agents administered by limb perfusion produce only temporary palliation.
No large series of cases of chondrosarcoma or fibrosarcoma of bone exists for the dog and comparison of the tumours at this stage is rather limited. Multiple myelomas, heemangiosarcomas and benign tumours of bone in the dog are extremely uncommon.
Tumours Metastatic to Bone
Both sarcomas and carcinomas metastasize to the skeleton and in man metastatic skeletal carcinomas from primary tumours in the breast, prostate and lung are common. Mammary tumours are of frequent occurrence in the bitch and more than half are of the mixed mammary type. Of the mammary carcinomas up to one-half may metastasize, the commonest sites being lymph nodes and lungs. The reported incidence of metastasis to bones in the bitch from mammary carcinoma is less than 10%, compared with more than 70% in women. Some of the reported wide difference in incidence may be apparent rather than real as euthanasia is usually performed on dogs with metastatic tumours before the natural history of the condition is completed. The lesions in the bone are mainly of the osteolytic type and in several cases periosteal new bone has been present which is an uncommon occurrence in women.
An interesting difference in the comparative oncology of man and dog is that prostatic carcinoma is uncommon in the dog. Primary tumours of lungs, thyroid and kidney are further examples of tumours which frequently metastasize to the skeleton in man but all of these primary tumours are uncommon in the dog.
